Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zenas BioPharma (ZBIO) Assets Average (2024 - 2025)

Zenas BioPharma (ZBIO) has 2 years of Assets Average data on record, last reported at $307.6 million in Q3 2025.

  • For Q3 2025, Assets Average changed N/A year-over-year to $307.6 million; the TTM value through Sep 2025 reached $307.6 million, changed N/A, while the annual FY2024 figure was $219.1 million, N/A changed from the prior year.
  • Assets Average reached $307.6 million in Q3 2025 per ZBIO's latest filing, down from $313.4 million in the prior quarter.
  • Across five years, Assets Average topped out at $386.7 million in Q4 2024 and bottomed at $307.6 million in Q3 2025.